Development and disease are controlled, to a large degree, by regions of genomic DNA called enhancers that encode binding sites for transcription factor proteins. Binding of activators and repressors increase and reduce gene expression levels, respectivel

In this webinar, we will present a novel capture resin that can be used to capture and purify target proteins via fusion to a 35 amino acid tag.

Evaluate Neutralization Activities for COVID-19 Vaccine and Drug Development

Enabling Precision Engineering with Synthetic Mutant Libraries

Genome Engineering allows the easy manipulation of genomes down to the nucleotide level.

The role of proteins that are central to RAD51 loading in homologous recombination are also important in the protection of stalled replication forks from degradation by nucleases. Many of these act to promote RAD51 accumulation on single-stranded DNA that

Join our webinar to learn how we fine-tune the semiconductor-based target enrichment to improve the capture of the most challenging regions with hybridization kits fit dsDNA/ssDNA probes.

Target identification in solid tumors can help enable therapeutic development against indications of high unmet need and across a wide patient population.

The SARS-CoV-2 pandemic necessitated the rapid development of high-quality monoclonal antibodies (mAbs) for therapeutic, diagnostic, and vaccine development.

Neoantigen based immuno-oncology therapies are proving promising, but neoantigen identification and production are bottlenecks to boosting efficacy.